These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 36531558)

  • 1. Effects of Isoflavone Supplementation on the Response to Medroxyprogesterone in Premenopausal Women with Nonatypical Endometrial Hyperplasia: A Randomized, Double-Blind, Placebo-Controlled Trial.
    Vahedpour Z; Boroumand H; Tabatabaee Anaraki S; Tabasi Z; Motedayyen H; Akbari H; Raygan F; Ostadmohammadi V
    Int J Clin Pract; 2022; 2022():1263544. PubMed ID: 36531558
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of isoflavone soy protein supplementation on endometrial thickness, hyperplasia, and endometrial cancer risk in postmenopausal women: a randomized controlled trial.
    Quaas AM; Kono N; Mack WJ; Hodis HN; Felix JC; Paulson RJ; Shoupe D
    Menopause; 2013 Aug; 20(8):840-4. PubMed ID: 23422867
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomized, double-blind, placebo-controlled, multicenter study that assessed the endometrial effects of norethindrone acetate plus ethinyl estradiol versus ethinyl estradiol alone.
    Portman DJ; Symons JP; Wilborn W; Kempfert NJ
    Am J Obstet Gynecol; 2003 Feb; 188(2):334-42. PubMed ID: 12592236
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of hormone replacement therapy on endometrial histology in postmenopausal women. The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial. The Writing Group for the PEPI Trial.
    JAMA; 1996 Feb; 275(5):370-5. PubMed ID: 8569016
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endometrial safety of ultra-low-dose estradiol vaginal tablets.
    Simon J; Nachtigall L; Ulrich LG; Eugster-Hausmann M; Gut R
    Obstet Gynecol; 2010 Oct; 116(4):876-883. PubMed ID: 20859151
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incidence of endometrial hyperplasia in postmenopausal women taking conjugated estrogens (Premarin) with medroxyprogesterone acetate or conjugated estrogens alone. The Menopause Study Group.
    Woodruff JD; Pickar JH
    Am J Obstet Gynecol; 1994 May; 170(5 Pt 1):1213-23. PubMed ID: 8178840
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Soy protein isolate with isoflavones does not prevent estradiol-induced endometrial hyperplasia in postmenopausal women: a pilot trial.
    Murray MJ; Meyer WR; Lessey BA; Oi RH; DeWire RE; Fritz MA
    Menopause; 2003; 10(5):456-64. PubMed ID: 14501608
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Effects of Folic Acid Supplementation on Recurrence and Metabolic Status in Endometrial Hyperplasia: A Randomized, Double-Blind, Placebo-Controlled Trial.
    Bahmani F; Rahimi Galougahi F; Vahedpoor Z; Jamilian M; Mahmoodi S; Baghban R; Bagherian T; Zarezade Mehrizi M; Asemi Z
    Arch Iran Med; 2018 Oct; 21(10):452-459. PubMed ID: 30415553
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of isoflavone supplementation on endometrial thickness, endometrial hyperplasia, and cancer in ovariectomized cats.
    Negadmonfared M; Narenji Sani R; Ghaffari Khaligh S; Hayati F
    Vet Ital; 2022 Nov; 58(1):35-39. PubMed ID: 35593501
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endometrial effects of lower doses of conjugated equine estrogens and medroxyprogesterone acetate.
    Pickar JH; Yeh I; Wheeler JE; Cunnane MF; Speroff L
    Fertil Steril; 2001 Jul; 76(1):25-31. PubMed ID: 11438315
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparing letrozole with medroxyprogesterone acetate (MPA) as hormonal therapy for simple endometrial hyperplasia without atypia in adult and middle-aged women.
    Tabatabaie A; Karimi Zarchi M; Dehghani-Tafti M; Miratashi-Yazdi A; Teimoori S; Dehghani A
    Eur J Gynaecol Oncol; 2013; 34(6):552-5. PubMed ID: 24601050
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of tibolone and continuous combined conjugated equine estrogen/medroxyprogesterone acetate on the endometrium and vaginal bleeding: results of the OPAL study.
    Langer RD; Landgren BM; Rymer J; Helmond FA;
    Am J Obstet Gynecol; 2006 Nov; 195(5):1320-7. PubMed ID: 16875644
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of bazedoxifene/conjugated estrogens on endometrial safety and bone in postmenopausal women.
    Mirkin S; Komm BS; Pan K; Chines AA
    Climacteric; 2013 Jun; 16(3):338-46. PubMed ID: 23038989
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endometrial effects of lower doses of conjugated equine estrogens and medroxyprogesterone acetate: two-year substudy results.
    Pickar JH; Yeh IT; Wheeler JE; Cunnane MF; Speroff L
    Fertil Steril; 2003 Nov; 80(5):1234-40. PubMed ID: 14607581
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of a soy isoflavone supplement on lung function and clinical outcomes in patients with poorly controlled asthma: a randomized clinical trial.
    Smith LJ; Kalhan R; Wise RA; Sugar EA; Lima JJ; Irvin CG; Dozor AJ; Holbrook JT;
    JAMA; 2015 May; 313(20):2033-43. PubMed ID: 26010632
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cyclic versus continuous medroxyprogesterone acetate for treatment of endometrial hyperplasia without atypia: a 2-year observational study.
    Emarh M
    Arch Gynecol Obstet; 2015 Dec; 292(6):1339-43. PubMed ID: 26015309
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Unopposed estradiol therapy in postmenopausal women: results from two randomized trials.
    Steiner AZ; Xiang M; Mack WJ; Shoupe D; Felix JC; Lobo RA; Hodis HN
    Obstet Gynecol; 2007 Mar; 109(3):581-7. PubMed ID: 17329508
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact on uterine bleeding and endometrial thickness: tibolone compared with continuous combined estradiol and norethisterone acetate replacement therapy.
    Dören M; Rübig A; Coelingh Bennink HJ; Holzgreve W
    Menopause; 1999; 6(4):299-306. PubMed ID: 10614676
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral and intrauterine progestogens for atypical endometrial hyperplasia.
    Luo L; Luo B; Zheng Y; Zhang H; Li J; Sidell N
    Cochrane Database Syst Rev; 2018 Dec; 12(12):CD009458. PubMed ID: 30521671
    [TBL] [Abstract][Full Text] [Related]  

  • 20. One-year randomized study of the endometrial safety and bleeding pattern of 0.25 mg drospirenone/0.5 mg 17β-estradiol in postmenopausal women.
    Genazzani AR; Schmelter T; Schaefers M; Gerlinger C; Gude K
    Climacteric; 2013 Aug; 16(4):490-8. PubMed ID: 23531117
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.